Form D · Venture Capital Fund
Bioverge Funds, LLC, ECHO I
San Francisco, CA · CIK 0001691592
Offering snapshot reported Dec 7, 2016 · SEC filing
- Reported sold
- $66K Offering amount: $66K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Nov 30, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2016 | Initial | $66,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275790
Source: Form D, filed Dec 7, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Na Bioverge Funds Management Llc | Director, Promoter |
| Neil Littman | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
970 Chestnut Street Apartment 6
San Francisco, CA, 94109
San Francisco, CA, 94109